1.4800 0.00 (0.00%)
After hours: 5:48PM EDT
|Bid||1.4800 x 2900|
|Ask||1.4900 x 4000|
|Day's Range||1.4700 - 1.5368|
|52 Week Range||1.3200 - 4.6500|
|Beta (3Y Monthly)||1.69|
|PE Ratio (TTM)||2.85|
|Earnings Date||Jul 24, 2019 - Jul 29, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.00|
GNC Holdings, Inc. (NYSE:GNC), which is in the specialty retail business, and is based in United States, saw a...
In some ways, all the enthusiasm for CBD oil reminds me of one of my best early trades. Back in 2003, I was walking in New York and people were wearing True Religion jeans everywhere I went. Then I discovered they were paying $200 for them. I bought a pair for myself, and they really were nice. So after my full analysis, I went ahead and bought the stock, too, just as the brand was taking off among the 18- to 34-year-old demographic.True Religion stock was less than a dollar at that time - but when I cashed out, it had run up above $20.Great investing ideas are like that. They're often very simple and right in front of us. They pop up in our daily lives… and we hear about them from friends and neighbors. Just like when everyone stopped renting movies and started getting little red envelopes in their mailbox.InvestorPlace - Stock Market News, Stock Advice & Trading TipsIf you started using Netflix (NASDAQ:NFLX) in the mid-2000s - instead of paying all those late fees to Blockbuster - then congratulations. You uncovered a great business model! Even if you didn't invest in Netflix (or not until much later), you spotted a game-changing company in its very early days.That's what it's all about. Netflix's success is not complicated, just like Facebook (NASDAQ:FB) or Amazon (NASDAQ:AMZN). People have firsthand experience with their products and services, and use them all the time. It's the power of what you know. * 7 Value Stocks to Buy for the Second Half It's Happening Again With CBD OilJust a few months ago, I was in New York again, at one of my favorite little coffee shops. This time everyone had a drink infused with cannabidiol (CBD) oil.A few days later, my girlfriend brought home a CBD lotion. She explained how it was derived from hemp and was an anti-inflammatory, plus it has antioxidant properties, to fight signs of aging and wrinkles. Basically it's the non-psychoactive "cousin" of marijuana - but since it doesn't have tetrahydrocannabinol (THC), it doesn't get you high.I tried CBD, too, and found that it really helps me mellow out to go to sleep. I swear by it. People like Michael J. Fox and Melissa McCarthy use it, too, but it's not just celebrities. If your experience is anything like mine, your friends and loved ones are starting to talk about trying CBD oil as well. People are even using it for their pets!Whether you have tried CBD or not, millions of people have. I think you're going to like the numbers on this one. Here's the latest on the CBD craze: * CBD was a $108 million market in 2014, and by 2022, it'll ring in at $22 billion, according to projections from the Brightfield Group. That's 20,270% growth in just eight years. * Besides the little neighborhood CBD shops that are popping up everywhere, you can also now buy it at CVS and Walgreens. Clearly, CBD products are starting to enter the mainstream. * Sephora and Ulta Beauty (NASDAQ:ULTA) now carry their own CBD products. So does GNC (NYSE:GNC), and Urban Outfitters (NASDAQ:URBN) and Kroger (NYSE:KR) will sell CBD, too. * People with seizure disorders have had great success using CBD to reduce their symptoms. That was how my favorite CBD stock got its start. * A lot of folks are using it to help manage pain, anxiety, depression, and sleep disorders, too. In fact, in one survey from the National Institutes of Health (NIH), about 36% of CBD users found that it was managing their condition "very well by itself." * The implications for CBD fighting the opioid crisis are huge. In a study published in the American Journal of Psychiatry in May, doctors administered CBD to people in recovery from heroin addiction. They found that CBD "significantly reduced both craving and anxiety," with "no significant effects on cognition, and there were no serious adverse effects."The companies providing all this CBD are raking it in - doubling their revenues over the past 12 months. But seeing as hemp-derived CBD just became legal six months ago, there's a lot more to come, especially given the sharp growth trajectory we saw earlier.All from just those little bottles of hemp oil at the drugstore and beauty shop!It reminds me of a famous story I heard on Wall Street. Peter Lynch, a legendary investor, once ran one of the top-performing mutual funds of all time: Fidelity's Magellan fund. Among his biggest winners was Dunkin' Donuts (NASDAQ:DNKN). Apparently he bought it because he liked the coffee - and it ended up being a 10-bagger.Then there's Bill Gates. He once tried fake chicken at a taco truck - it was made out of pea protein, but he couldn't tell the difference from the real thing. His investment in Beyond Meats (NASDAQ:BYND) has paid off handsomely after the company just had one of the best IPOs of the year.That's the "power of what you know."And now I think CBD could be your "power of what you know" moment. CBD Early Investor's KitNow is the time to invest while the stocks are still small. And small companies are the job creators. The innovators. Invest in a high-quality business model in its early days - and once it takes off… that's how fortunes are made.I believe in this opportunity, so this week I'll be sharing a series of articles to help you truly "know" about it.I've also been working with my publisher to put together a complete CBD Early Investor's Kit. We've got enough for the first 4,000 respondents, and here's what you get: * The 1 CBD Stock in the World. One little company has been eating up much of the U.S. market share in CBD, because it can produce a higher-quality product - and lots of it. I've got a whole investment guide to fill you in before the crowd catches on. * Three More CBD Stocks to Fatten Your Wallet. These other CBD stocks are quietly doubling revenues, tempting away top executives from household brands, and striking sweet deals on new product lines. You'll see their names, ticker symbols, and buy-under prices in my full report. * Plus, to help you really get to know the product, you'll also get a 15-day supply of high-grade CBD from CannaComplete. If you're like me, you like to see what all the fuss is about firsthand. That's why, on my recent trip, I went to the "Starbucks of China." I wasn't impressed with that but I do understand the CBD craze, now that I've taken part. There's a lot of weird rumors about CBD, from haters and fanatics. Now you can see the real deal for yourself.Those of us who have tried CBD know that its appeal is simple and straightforward. Just like with Netflix and Facebook - or with True Religion, back in the day - that's what makes it powerful.As investors, there are plenty of avenues we can take to cash in on the CBD craze. Click here for more details and to claim one of these research packages now.Matthew McCall is the founder and president of Penn Financial Group, an investment advisory firm, as well as the editor of Investment Opportunities and Early Stage Investor. He has dedicated his career to getting investors into the world's biggest, most revolutionary trends BEFORE anyone else. The power of being "first" gave Matt's readers the chance to bank +2,438% in Stamps.com (STMP), +1,523% in Ulta Beauty (ULTA), +1,044% in Tesla (TSLA), +611% in Liquefied Natural Gas Limited (LNGLY), +324% in Bitcoin Services (BTSC), just to name a few. If you're interested in making triple-digit gains from the world's biggest investment trends BEFORE anyone else, click here to learn more about Matt McCall and his investments strategy today. More From InvestorPlace * 4 Top American Penny Pot Stocks (Buy Before June 21) * 7 Value Stocks to Buy for the Second Half * 7 Hot Stocks to Buy for a Seemingly Sleepy Summer * 6 Chip Stocks Staring At Big Headwinds in 2019 Compare Brokers The post CBD Oil: The True Power of a Consumer Craze appeared first on InvestorPlace.
GNC (GNC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...
To take a flyer or not to take a flyer on GNC Holdings (GNC)? On the other, free cash flow is still 6x greater than capital spending at $120 million, and GNC's stores are still generating over $564 million in quarterly sales, with the April earnings announcement reporting a slight rise in Ebita to $65.9 million. Warning! GuruFocus has detected 3 Warning Signs with GNC.
Despite year-over-year decline in earnings and revenues, better performing International segment and key developments favor GNC Holdings (GNC) in Q1.
GNC Holdings Inc. stock skyrocketed 10.3% in Thursday premarket trading after the nutritional supplement seller reported first-quarter sales that fell, but beat expectations. GNC had a loss of $15.3 million, or 23 cents per share, after income of $6.2 million, or 7 cents per share, in 2018. Adjusted EPS was 15 cents. Revenue of $564.8 million was down from $607.5 million. The company blamed the sales decline on the transfers of Nutra manufacturing and China e-commerce business to newly-formed joint ventures, as well as the shuttering of company-owned stores. The FactSet consensus was for EPS of 18 cents and sales of $552.0 million. "During the past six months we have completed a number of important partnerships, including the strategic investment by Harbin and the joint ventures with Harbin and IVC, which further enable our team to focus on our core business. In addition, during that period, we have improved our balance sheet by retiring over $350 million in debt," said GNC Chief Executive Ken Martindale in a statement. GNC stock has taken a 14% tumble in 2019 while the S&P 500 index has rallied 16.8%.
The Pittsburgh-based company said it had a loss of 23 cents per share. Earnings, adjusted for one-time gains and costs, came to 15 cents per share. The nutritional supplement retailer posted revenue of ...
Domestic same store sales decreased 1.6%; International segment revenue, excluding China, increased 13% Net loss of $15.3 million for the first quarter of 2019 including.
GNC Holdings Inc., a leading global health and wellness brand, announced that the company is now offering topical cream products containing cannabidiol (CBD), in select retail locations and online in 23 states and the District of Columbia. The available Physician’s Grade products include the company’s face creams, luxe body lotion, scalp treatment and revitalizing shampoo. Myaderm’s offerings include their four popular topical creams, which are the CBD Body Cream, available in two sizes, the Double Strength CBD Body Cream and the CBD Sport Cream.
PITTSBURGH, April 11, 2019 -- GNC Holdings, Inc. (NYSE: GNC), a leading global health and wellness brand, will release results for the first quarter of 2019 before the market.
TSX: BCB) has appointed William "Jamie" Jamieson as its global chief information officer. The appointment is effective immediately and Jamieson will report directly to Cott CEO Tom Harrington. In his role, Jamieson will lead the corporation’s global information technology function and play a key role in shaping the technology agenda across the Cott family of businesses.
A California firm is firing back at vitamin retailer General Nutrition Corporation (GNC), denying wrongdoing when it comes to a pair of stores in North Carolina – including one in Raleigh.
GNC Holdings’ general counsel for employment and franchising has joined the Pittsburgh office of Cozen O’Connor PC. Gary Kelly had worked at GNC (NYSE:GNC) since 2000, responsible for developing and implementing the health and fitness retailer’s legal policies and overseeing all litigation. The firm also hired Laura Reinhart, a Burns White member known for defending transportation companies in Federal Employment Liability Act-related litigation.
GNC Holdings Inc (NYSE:GNC) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018.
Penguins' exec says new plan for former arena site featuring increases in office and retail space is "tenant driven" with new office tower estimated to range between 30 and 50 stories.
Please replace the release dated February 19, 2019 with the following corrected version due to multiple revisions.